BioSpace News Archive

BioMidwest

Novel Treatment Provides New Hope for Relief of Disabling Stroke Pain - Institute of Neurological Recovery

Two new publications provide hope for relief from disabling pain due to stroke, a chronic condition that afflicts hundreds of thousands of stroke survivors in the U.S.

October 23, 2019
·
2 min read
Business

Dartmouth-Hitchcock Health, West Health Partner to Create Nation’s First Rural Geriatric Emergency Department

$4.5 million research collaboration will combine geriatrics, emergency medicine, telehealth to benefit Northern New England seniors

October 23, 2019
·
5 min read
Biotech Beach

Wexford Health Sources, Inc. Selects NantHealth’s Eviti® Connect to Bring Evidence-Based Standards and Value-Based Oncology Care to Patients

NantHealth, Inc., a next-generation, evidence-based, personalized healthcare company, announced its new customer, Wexford Health Sources, Inc.

October 23, 2019
·
3 min read
Business

Thermo Fisher Scientific Reports Third Quarter 2019 Results

Thermo Fisher Scientific Inc., the world leader in serving science, reported its financial results for the third quarter ended September 28, 2019.

October 23, 2019
·
25 min read
Business

Magellan Health Announces Third Quarter 2019 Earnings Conference Call

Magellan Health, Inc. announced that it will report its earnings for the third quarter ended on September 30, 2019 at approximately 6:30 a.m. Eastern on Friday, November 1, 2019. At 8:00 a.m.

October 23, 2019
·
1 min read
Policy

Bausch Health Licenses Clearside Biomedical’s XIPERE™ (Triamcinolone Acetonide Suprachoroidal Injectable Suspension), An Investigational Treatment For Macular Edema Associated With Uveitis

NDA Resubmission to the FDA Expected to Occur in the First Quarter of 2020

October 23, 2019
·
8 min read
Business

Axogen, Inc. to Report Third Quarter 2019 Financial Results and Host Conference Call on November 6, 2019

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced that it will report third quarter 2019 financial results on Wednesday, November 6, 2019 after the market closes.

October 23, 2019
·
2 min read
Business

Akcea Announces Appointment of New Chief Commercial OfficerKyle Jenne promoted from previous role as U.S. commercial lead to support continued strategic expansion of global commercial operations

Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., announced today that the company has promoted Kyle Jenne to chief commercial officer.

October 23, 2019
·
4 min read
Biotech Beach

Guardion® Receives approval from USPTO for expanded claims for its Proprietary Medical Device, the MAPCAT SF

Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced that it has received approval from the USPTO for additional claims reflected in a new patent for its proprietary medical device, the MapcatSF®.

October 23, 2019
·
3 min read
Pharm Country

Tonix Pharmaceuticals Announces Issuance of U.S. Patent for Crystalline Tianeptine Oxalate Salt, the Active Ingredient of TNX-601

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that the U.S. Patent and Trademark Office (“USPTO”) issued U.S. Patent No. 10,449,203 to the Company on October 22, 2019.

October 23, 2019
·
5 min read